|
|
.
See Category: Neoplasms
See Header: Lobular carcinoma in situ of breast
ICD-10 (CM) Code and Descriptor
|
D05.02 |
Lobular carcinoma in situ of left breast
|
D0502 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 50.98%
|
23.03%
|
10.96%
|
5.32%
|
3.17%
|
2.14%
|
1.36%
|
0.96%
|
0.53%
|
0.40%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for D05.02*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
979
|
987
|
|
88307
|
TISSUE EXAM BY PATHOLOGIST |
624
|
1,064
|
|
88342
|
IMHCHEM/IMCYTCHM 1ST ANTB |
548
|
771
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
521
|
16,075
|
|
J3010
|
FENTANYL CITRATE INJECTION |
496
|
898
|
|
J2405
|
ONDANSETRON HCL INJECTION |
447
|
1,994
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
428
|
641
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
406
|
1,576
|
|
88341
|
IMHCHEM/IMCYTCHM EA ADD ANTB |
397
|
1,007
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
369
|
372
|
|
80053
|
COMPREHEN METABOLIC PANEL |
350
|
350
|
|
76098
|
X-RAY EXAM SURGICAL SPECIMEN |
340
|
374
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
336
|
336
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
335
|
2,169
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
287
|
1,478
|
|
77065
|
DX MAMMO INCL CAD UNI |
286
|
286
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
282
|
559
|
|
A4648
|
IMPLANTABLE TISSUE MARKER |
277
|
349
|
|
19301
|
PARTIAL MASTECTOMY |
269
|
268
|
|
G0279
|
TOMOSYNTHESIS, MAMMO |
267
|
267
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
D05.02 related to the following DRG Codes:
582-583
597-599
|
